ISO 11135 – EtO Sterilization for Medical Devices

/
/
/
/
ISO 11135 – EtO Sterilization for Medical Devices

Overview

ISO 11135 exists to ensure aseptic presentation at point of use when EtO is the sterilant. The standard expects you to define a robust process window, prove it with a defensible validation, and control it routinely in production. That means more than just hitting an exposure time—your file must connect EO concentration, humidity, temperature, and aeration to the sterility assurance level (SAL) you claim, without exceeding residual limits.

Where ISO 11135 fits

  • Works alongside ISO 11607 (sterile barrier systems) and ISO 10993-7 (EO residuals).
  • Aligns with FDA & EU expectations for terminal sterilization.

Applicable whether you sterilize in-house or through a contract EtO provider.

At LSO, EtO sterilization is performed in-house, so validation, test coordination, and routine production control happen under one roof for faster turnaround and cleaner audits.

How EtO Sterilization Works in ISO 11135

EtO sterilization isn’t “set-and-forget.” Sterility depends on gas penetration into your load, which is driven by preconditioning, moisture, temperature, and the EO concentration/time you can actually achieve in your chamber and packaging system. ISO 11135 wants that cause-and-effect nailed down and demonstrated with half-cycles, overkill or BI/bioburden methods, and documented process equivalence when product or packaging changes.

Plain-English keys:

  • Preconditioning: Prepare the load (temp/RH) so EO can penetrate.
  • Exposure: EO concentration × time × temp × RH achieve SAL 10⁻⁶.
  • Aeration: Remove EO/EG so residuals meet ISO 10993-7 limits.
  • Release: Use defined criteria, not “looks good.”

Validation Flow (IQ/OQ/PQ) & Routine Control

IQ – Installation Qualification

Confirm chamber, sensors, gas delivery, and software/PLC are installed and calibrated as designed. Map locations that matter (e.g., thermocouples, RH probes).

OQ – Operational Qualification

Prove you can achieve and control the defined process window empty/with PCDs—e.g., temp/RH ramps, EO delivery, evacuation profiles, and aeration performance. Define alarm limits, cycle holds, and release criteria.

PQ – Performance Qualification

Run product-equivalent loads (min/nominal/max) with worst-case packaging and BI placement to demonstrate the validated cycle consistently delivers SAL. Include half-cycle or overkill as justified. Document equivalency rules for new SKUs, changes, and requal.

Routine control
  • Parametric release where justified (with strict criteria), or sterility tests per plan.
  • Load configuration control and PCD integrity checks.
  • Re-qualification triggers: chamber maintenance, new packaging/geometry, material changes, bioburden shifts.


How LSO helps: Protocols, PCD strategy, BI placement logic, half-cycle design, test coordination, documentation, and change-control rules you can defend. LSO’s in-house preconditioning, exposure, and aeration mirror your qualified window in production and support parametric release when your program justifies it.

Packaging & Product Considerations

EtO (ethylene oxide) is effective with porous sterile barrier materials, but not all porosity types are the same. The standard requires proof that your barrier allows for gas exchange during exposure while still providing protection after aeration. Here are some practical checks:

  • Assess the seal’s integrity and strength through methods like peel, creep, and burst tests, which align with ISO 11607 standards.
  • Determine whether you’re using trays, films, pouches, header bags, or custom porosity—all of which require validation of gas pathways and moisture effects.
  • Recognize that load density and unit orientation can influence gas access; manage these factors carefully or be prepared to re-qualify your process.

Residues, Biocompatibility & Aeration

Validation doesn’t stop at sterility. You must prove EO/EG residuals meet ISO 10993-7 limits at release (and at labeled storage, if relevant). That requires:

  • Aeration performance studies (time/temperature) on worst-case product.
  • Analytical testing plan and acceptance criteria.
  • Label claims backed by real clearance kinetics.

Common Pitfalls & How to Avoid Them

  • Assuming contract EtO = automatic compliance. You still own the file: product equivalence, PCD rationale, load config, and re-qual rules.
  • Weak preconditioning logic. RH/temp ramp rates matter—auditors ask why your ramp is defensible for the actual packaging system.
  • BI placement that misses worst-case. Use airflow paths, porosity, and density to defend placements.
  • Residuals tested on the “easy” SKU. Pick the slowest-clearing device/material combo.
  • Release criteria that don’t match validation. Your routine spec must mirror the PQ window.

What Auditors Emphasize Now

  • Traceability: Begin with the requirement, followed by the corresponding protocol step, then gather the raw data, draw conclusions, and finally establish the release criteria.
  • Equivalency: Evaluate how new SKUs or packaging perform under the validated production cycle.
  • Change Control: Identify practical triggers, such as material changes, geometric alterations, shelf box variations, and load orientation adjustments.
  • Data Integrity: Ensure proper sensor calibration, manage BI control lots, and address outlier handling.
  • Residuals Linkage: Connect aeration settings to the 10993-7 limits concerning worst-case scenarios.

“Great EtO validations read like a map: anyone can follow the trail from process window to routine release—and know exactly when to re-test.”

Souk Phimphasone, Sterilization Validation Engineer (LSO)

In-House EtO Facility Highlights

  • GMP-compliant EtO chambers with calibrated sensors and data integrity controls
  • Preconditioning & aeration rooms with controlled temp/RH and monitored clearance
  • EO emissions controls and continuous worker-safety monitoring (OSHA/EPA/local compliance)
  • Parametric release support (where justified), or sterility-test release per plan

How LSO Can Help

  • Validation planning & protocols (IQ/OQ/PQ), PCD strategy, and BI placement to match device geometry and sterile barrier systems
  • EtO cycle development & load configuration with defensible worst-case rationale
  • Test coordination for BIs, seal/peel/burst, dye, aging, and ISO 10993-7 residuals
  • In-house EtO sterilization with GMP-compliant chambers, preconditioning, and aeration; parametric release supported where justified
  • Audit-ready documentation and change control (with defined re-qualification triggers)

Sign up for email resources!

Receive the latest infographics, guides, and blog updates for medical device manufacturing, package testing, and sterilization.